Acyl glucuronides: the good, the bad and the ugly
Sophie L Regan1, James L Maggs, Thomas G Hammond
1MRC Centre for Drug Safety Science, Institute of Translational Medicine, The University of Liverpool, Liverpool L69 3GE, UK. s.l.regan@liv.ac.uk
Biopharmaceutics & Drug Disposition
|September 11, 2010
Summary
Acyl glucuronides, major drug metabolites, can react with proteins, potentially causing adverse drug reactions. However, their in vivo impact remains uncertain due to limited evidence and rapid clearance.
Area of Science:
- Pharmacology
- Toxicology
- Drug Metabolism
Background:
- Acyl glucuronidation is a primary metabolic pathway for carboxylic acid drugs.
- Acyl glucuronides exhibit unique reactivity, leading to protein binding and potential toxicity.
- The link between acyl glucuronide-protein adducts and adverse drug reactions is debated.
Purpose of the Study:
- To review the reactivity, stability, and pharmacokinetics of acyl glucuronides.
- To assess the physiological, pharmacological, and toxicological implications of acyl glucuronidation.
- To clarify the in vivo relevance of acyl glucuronide-protein interactions in drug safety.
Main Methods:
- Literature review of acyl glucuronide properties and in vivo/in vitro studies.
- Analysis of acyl glucuronide reactivity, metabolic stability, and pharmacokinetic profiles.
- Evaluation of existing evidence for protein adduct formation and its toxicological significance.
Main Results:
- Acyl glucuronides undergo transacylation and glycation reactions with proteins in vitro.
- In vivo evidence for acyl glucuronide-protein adducts is limited and potentially ambiguous.
- Rapid clearance of acyl glucuronides in vivo may limit their interaction with proteins.
Conclusions:
- The in vivo toxicological significance of acyl glucuronides requires further investigation.
- Pharmacokinetic analysis of acyl glucuronides alongside protein adduct levels is crucial.
- It remains uncertain if acyl glucuronide clearance prevents endogenous protein modification and immune responses.
Related Concept Videos
01:24Phase II Reactions: Glucuronidation
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
01:14Drug Metabolism: Phase II Reactions
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
01:22Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
01:19Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme activation, sulfur...
01:05Proteoglycans
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
01:14Phase II Conjugation Reactions: Overview
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...